December 23, 2011 -- Frontage Laboratories officially opened a renovated clinical-stage facility in Jilin University Hospital, which it has been operating since earlier this year. Frontage is a US-China CRO with a pre-clinical toxicology facility in Shanghai and a drug development operation in Beijing. The Jilin hospital facility will offer early phase oncology research studies. More details....
